Artificial neural networks: A study in clinical psychopharmacology

Psychiatry Research

Volumn 87, Issue 2-3, 1999, Pages 203-215

  Politi, Ernestina ^a   Balduzzi, Carlo ^a   Bussi, Riccardo ^a   Bellodi, Laura ^a  

^a Anxiety Disord Clin and Res Unit   (Italy)

Author keywords

Affective disorder; Anxiety disorder; Moclobemide; Statistics; Systems theory; Treatment outcome

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MOCLOBEMIDE;

ADOLESCENT; ADULT; AFFECTIVE NEUROSIS; AGED; ANXIETY; ARTIFICIAL NEURAL NETWORK; CLINICAL RESEARCH; CLINICAL TRIAL; DECISION MAKING; DRUG EFFICACY; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PANIC; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SOCIAL PHOBIA; THEORY; TREATMENT OUTCOME;

EID: 0032697035     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00049-9     Document Type: Article

References (72)

1. Ackoff R. Future of operational research in past. General Systems Yearbook. 24:1979;241-252.
2. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. 1994;A.P.A. Press, Washington, D.C.
3. Ashby R. Some peculiarities of complex systems. Cybernetic Medicine. 9(2):1973;1-6.
4. Attikiouzel Y., de Silva C.J. Applications of neural networks in medicine. Australasian Physical and Engineering Sciences in Medicine. 18(3):1995;158-164.
5. Aussem A., Murtagh F., Sarazin M. Dynamically recurrent neural networks. Towards environmental time series prediction. International Journal of Neural Systems. 6(2):1995;145-170.
6. Bailey K.D. Equilibrium, entropy and homeostasis. Systems Research. 1(1):1984;25-43.
7. Bakish D., Saxena B.M., Bowen R., D'Souza J. Reversible monoamine oxidase-A inhibitors in panic disorder. Clinical Neuropharmacology. 16(Suppl 2):1993;S77-82.
8. Baxt W.G., Skora J. Prospective validation of artificial neural network trained to identify acute myocardial infarction. Lancet. 347(8993):1996;12-15.
9. Biczyk do Amaral M., Satomora Y., Honda M., Sato T. A design for decision making: construction and connection of knowledge bases for a diagnostic system in medicine. Medical Informatics. 18(4):1993;307-320.
10. Bobbio M. La certezza della malattia e la probabilità della guarigione. Epidemiologia e Prevenzione. 17:1993;194-196.
11. Boulding K. General systems theory. The skeleton of science. General Systems Yearbook. 1:1956;11-17.
12. Brahams D., Wyatt J. Decision aids and the law. Lancet. 1:1989;632-634.
13. Callaway E. Psychopharmacology's need for linking variables. Biological Psychiatry. 32:1992;1-3.
14. Checkland P. Science and systems paradigm. International Journal of General Systems. 3(2):1976;127-134.
15. Churchland P.S., Sejnowski T.J. The Computational Brain. 1992;MIT Press, Cambridge, MA.
16. Cohen J. Clinical trial monitoring: hit or miss? Science. 264:1994;1534-1537.
17. Conant R., Ashby R. Every good regulator of systems must be model of that systems. International Journal of Systems Science. 1(2):1970;89-97.
18. Davis C., Ralevski E., Kennedy S.H., Neitzert C. The role of personality factors in the reporting of side effects complaints to moclobemide and placebo: a study of healthy male and female volunteers. Journal of Clinical Psychopharmacology. 15(5):1995;347-352.
19. Dawes R.M., Faust D., Meehl P.E. Clinical versus actuarial judgement. Science. 243:1989;1668-1674.
20. Dawkins R. The Selfish Gene. 1989;Oxford University Press, Oxford.
21. De Vanna M., Kummer J., Agnoli A. Moclobemide compared with second-generation antidepressants in elderly people. Acta Psychiatrica Scandinavica. Suppl 160:1990;64-66.
22. Detmer D.E., Frayback D.G., Gassner K. Heuristics and biases in medical decision making. Journal of Medical Education. 53:1978;682-683.
23. Dodd F. Neural networks in pharmacology: models of mental disorders and effects of drug treatment. Nordic Journal of Psychiatry. 47(Suppl. 28):1993;17-26.
24. Edelman G.M. Neural Darwinism. 1987;Basic Books, New York.
25. Clinical trials and clinical practice. Lancet. 342:1993;877-878.
26. Evidence based medicine. Lancet. 346:1995;785.
27. Faust D., Ziskin J. The expert witness in psychiatry and psychology. Science. 241:1988;31-35.
28. Feibleman J., Friend J.W. The structure and function of organization. Philosophical Review. 54:1945;19-44.
29. Feinstein A.R. An additional basic science for clinical medicine. II. The limitations of randomized trials. Annals of Internal Medicine. 99:1983;544-561.
30. Feinstein A.R. Current problems and future challenges in randomized clinical trials. Circulation. 70:1984;767-774.
31. Floreano, D., 1996. Manuale sulle Reti Neurali. Il Mulino, Bologna.
32. Florio T., Einfeld S., Levy F. Neural networks and psychiatry: candidate applications in clinical decision making. Australian and New Zealand Journal of Psychiatry. 28(4):1994;651-666.
33. Foulds G.A. Clinical research in psychiatry. Journal of Mental Sciences. 104:1958;259-265.
34. Fulton B., Benfield P. Moclobemide. An update of its pharmacological properties and therapeutic use. Drugs. 52(3):1996;450-474.
35. Gardner M.R., Ashby R. Connectance of large dynamic (cybernetic) systems. Nature. 228(5273):1970;784.
36. Gorman R.P., Sejnowski T.J. Analysis of hidden units in a layered network trained to classify sonar targets. Neural Networks. 1:1988;75-89.
37. Halgamuge S.K., Glesner M. Fuzzy networks: between functional equivalence and applicability. International Journal of Neural Systems. 6(2):1995;185-196.
38. Hecht A. Synergetik: ein moglicher Denkansatz zum besseren Verstehen pathologischer Prozesse. Wiener Medizinische Wochenschrift. 141(16):1991;364-368.
39. Hopfield J. Neural networks and physical systems with emergent collective computational abilities. Proceedings of the National Academy of Sciences USA. 79:1982;2554-2558.
40. Hornik K., Stinchcombe M., White H. Multilayer feedforward networks are universal approximators. Neural Networks. 2:1989;359-368.
41. Horwitz R., Coulter H.O. Complexity and contradiction in the results of randomized clinical trials. Clinical Research. 32:1984;225A.
42. Ketley D., Woods K.L. Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction. Lancet. 342:1993;891-894.
43. Klienmuntz B. Why we still use our heads instead of formulas: toward an integrative approach. Psychological Bulletin. 107:1991;296-310.
44. Klir G. On the relation between cybernetics and general systems theory. Rose J. Progress in Cybernetics. 1:1970;155-165 Gordon and Breach, London.
45. Kohonen T. An introduction to neural computing. Neural Networks. 1:1988;3-16.
46. Lehky S.R., Sejnowski T.J. Neural network model of visual cortex for determining surface curvature from images of shaded surfaces. Proceedings of the Royal Society of London. B240:1990;251-278.
47. Levine D.S. Introduction to Neural and Cognitive Modeling. 1991;Lawrence Erlbaum, Hillsdale, N.J.
48. Liebowitz M.R., Schneier F., Gitow A., Feerick J. Reversible monoamine oxidase-A inhibitors in social phobia. Clinical Neuropharmacology. 16(Suppl. 2):1993;S83-88.
49. Lugosi G., Zeger K. Non-parametric estimation via empirical risk minimization. IEEE Transactions on Information Theory. 41:1995;677-678.
50. Mackey M.C., Glass L. Oscillation and chaos in physiological control systems. Science. 197:1977;287-289.
51. Miller J.G. Can systems theory generate testable hypotheses? Systems Research. 3(2):1986;73-84.
52. Nowak R. Problems in clinical trials go far beyond misconduct. Science. 264:1994;1538-1541.
53. Paykel E.S. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression. Acta Psychiatrica Scandinavica. 91(Suppl. 386):1995;22-27.
54. Pepper S.C. World Hypotheses. 1950;University of California Press, Berkeley.
55. Pocock S.J., Hughes M.D. Estimation issues in clinical trials and overviews. Statistics in Medicine. 9:1990;657-671.
56. Rapoport A. Mathematical aspects of general systems theory. General Systems Yearbook. 11:1962;3-11.
57. Rapp P.E., Schmah T. Complexity measures in molecular psychiatry. Molecular Psychiatry. 1:1996;408-416.
58. Ripley B.D. Pattern recognition and neural networks. 1996;Cambridge University Press, Cambridge.
59. Rumelhart D.E., McClelland J.L. Parallel distributed processing: explorations in the microstructure of cognition, Vols. 1 and 2. 1986;MIT Press, Cambridge, MA.
60. Sejnowski T.J., Rosemberg C.R. Parallel networks that learn to pronounce English text. Complex Systems. 1:1987;145-168.
61. Shannon E., Weaver W. A Mathematical Theory of Communication. 1949;University of Illinois Press, Urbana, IL.
62. Silverstone T. Moclobemide-placebo controlled trials. International Clinical Psychopharmacology. 7(3-4):1993;133-136.
63. Smith R.L. Systemic, not just systematic. Systems Research. 6(1):1989;27-37.
64. Spiker B. Guide to Clinical Interpretation of Data. 1986;Raven Press, New York.
65. StatSoft Inc., 1993. Statistica for Windows 4.5. Tulsa, OK.
66. The Math Works, Inc., 1997. MATLAB 5.1, Neural Network Toolbox 2.0.4. Natick, MA.
67. Tversky A., Kahneman D. Judgement under uncertainty: heuristics and biases. Science. 185:1974;1124-1231.
68. Von Bertalanffy L. The theory of open systems in physics and biology. Science. 111:1950;23-29.
69. Weigend A.S., Srivastava A.N. Predicting conditional probability distributions: a connectionist approach. International Journal of Neural Systems. 6(2):1995;109-118.
70. Wicken J. Entropy and information: suggestions for a common language. Philosophy of Science. 54(2):1987;176-193.
71. Young, D., Chapman, A., Poile, C., 1990. Physician, reveal thyself. British Journal of Healthcare Computing, 16-21.
72. Zadeh L.A. Fuzzy sets and systems. Fox J. Systems Theory. 1965;29-37 Polytechnic Press, Brooklyn, NY.